Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.26), which may not compare to the analyst estimate of ($0.04). Revenue for the quarter came in at $246.1 million versus the consensus estimate of $232.89 million.

For earnings history and earnings-related data on Insulet (PODD) click here.